|
||||||||
![]() |
Matthew D'Amore Partner
Email: mdamore@mofo.com Phone: (212) 468-8168 Fax: (212) 468-7900 |
Mr. D'Amore's practice includes representing clients in complex federal litigation, particularly patent litigation and securities class action. Mr. D'Amore also consults for technology companies on securities, patent and intellectual property issues. He has advised clients in a broad range of industries, including medical devices, pharmaceuticals, biotechnology, Internet technology, software, interactive television, electronics, semiconductors, and manufacturing. Mr. D'Amore is admitted to practice in the New York State Courts, the United States District Courts, for the Southern and Eastern Districts of New York, the United States Courts of Appeal for the Federal Circuit, and before the U.S. Patent and Trademark Office.
Mr. D'Amore has helped clients resolve disputes involving all areas of intellectual property as well as antitrust, securities, regulatory and general commercial matters. He also has an active pro bono practice, having represented disabled children denied special education services and Medicaid beneficiaries denied certain entitlements. Mr. D’Amore was recently appointed as an Adjunct Professor at Cornell Law School for the Spring 2007 term.
Mr. D'Amore is the Hiring Partner for the New York Office and is also involved in the firm's technology decision making, serving on Morrison & Foerster's Technology Strategy Committee for several years, and more recently helping to investigate new litigation and practice support tools for use by the firm.
Representative Matters
- Korszun v. Public Technologies Multimedia (D. Conn., Fed. Cir.): won summary judgment of non-infringement for client in software patent case.
- Weisman v. Omron Healthcare, Inc. (N.D. Ill. ): won bench trial for client in medical devices patent case on defense of laches.
- In Re IPO Securities Litigation (S.D.N.Y.): Represented 40 companies in consolidated securities litigation; Morrison & Foerster acted as liaison counsel for 300 companies and 1000 plus individuals.






